421 related articles for article (PubMed ID: 15731030)
1. Mucosal adjuvant properties of mutant LT-IIa and LT-IIb enterotoxins that exhibit altered ganglioside-binding activities.
Nawar HF; Arce S; Russell MW; Connell TD
Infect Immun; 2005 Mar; 73(3):1330-42. PubMed ID: 15731030
[TBL] [Abstract][Full Text] [Related]
2. Mutants of type II heat-labile enterotoxin LT-IIa with altered ganglioside-binding activities and diminished toxicity are potent mucosal adjuvants.
Nawar HF; Arce S; Russell MW; Connell TD
Infect Immun; 2007 Feb; 75(2):621-33. PubMed ID: 17118982
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
[TBL] [Abstract][Full Text] [Related]
4. Binding to gangliosides containing N-acetylneuraminic acid is sufficient to mediate the immunomodulatory properties of the nontoxic mucosal adjuvant LT-IIb(T13I).
Nawar HF; Berenson CS; Hajishengallis G; Takematsu H; Mandell L; Clare RL; Connell TD
Clin Vaccine Immunol; 2010 Jun; 17(6):969-78. PubMed ID: 20392887
[TBL] [Abstract][Full Text] [Related]
5. LT-IIb(T13I), a non-toxic type II heat-labile enterotoxin, augments the capacity of a ricin toxin subunit vaccine to evoke neutralizing antibodies and protective immunity.
Greene CJ; Chadwick CM; Mandell LM; Hu JC; O'Hara JM; Brey RN; Mantis NJ; Connell TD
PLoS One; 2013; 8(8):e69678. PubMed ID: 23936344
[TBL] [Abstract][Full Text] [Related]
6. Differential binding of Escherichia coli enterotoxins LT-IIa and LT-IIb and of cholera toxin elicits differences in apoptosis, proliferation, and activation of lymphoid cells.
Arce S; Nawar HF; Russell MW; Connell TD
Infect Immun; 2005 May; 73(5):2718-27. PubMed ID: 15845474
[TBL] [Abstract][Full Text] [Related]
7. Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins.
Connell TD
Expert Rev Vaccines; 2007 Oct; 6(5):821-34. PubMed ID: 17931161
[TBL] [Abstract][Full Text] [Related]
8. LT-IIc, a new member of the type II heat-labile enterotoxin family, exhibits potent immunomodulatory properties that are different from those induced by LT-IIa or LT-IIb.
Nawar HF; Greene CJ; Lee CH; Mandell LM; Hajishengallis G; Connell TD
Vaccine; 2011 Jan; 29(4):721-7. PubMed ID: 21095251
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 2 mediates cellular activation by the B subunits of type II heat-labile enterotoxins.
Hajishengallis G; Tapping RI; Martin MH; Nawar H; Lyle EA; Russell MW; Connell TD
Infect Immun; 2005 Mar; 73(3):1343-9. PubMed ID: 15731031
[TBL] [Abstract][Full Text] [Related]
10. Comparative Adjuvant Effects of Type II Heat-Labile Enterotoxins in Combination with Two Different Candidate Ricin Toxin Vaccine Antigens.
Vance DJ; Greene CJ; Rong Y; Mandell LM; Connell TD; Mantis NJ
Clin Vaccine Immunol; 2015 Dec; 22(12):1285-93. PubMed ID: 26491037
[TBL] [Abstract][Full Text] [Related]
11. Mammalian cell ganglioside-binding specificities of E. coli enterotoxins LT-IIb and variant LT-IIb(T13I).
Berenson CS; Nawar HF; Yohe HC; Castle SA; Ashline DJ; Reinhold VN; Hajishengallis G; Connell TD
Glycobiology; 2010 Jan; 20(1):41-54. PubMed ID: 19749203
[TBL] [Abstract][Full Text] [Related]
12. Distinctive immunomodulatory and inflammatory properties of the Escherichia coli type II heat-labile enterotoxin LT-IIa and its B pentamer following intradermal administration.
Mathias-Santos C; Rodrigues JF; Sbrogio-Almeida ME; Connell TD; Ferreira LC
Clin Vaccine Immunol; 2011 Aug; 18(8):1243-51. PubMed ID: 21677110
[TBL] [Abstract][Full Text] [Related]
13. The Divergent CD8+ T Cell Adjuvant Properties of LT-IIb and LT-IIc, Two Type II Heat-Labile Enterotoxins, Are Conferred by Their Ganglioside-Binding B Subunits.
Hu JC; Greene CJ; King-Lyons ND; Connell TD
PLoS One; 2015; 10(11):e0142942. PubMed ID: 26565800
[TBL] [Abstract][Full Text] [Related]
14. TLR2-dependent modulation of dendritic cells by LT-IIa-B5, a novel mucosal adjuvant derived from a type II heat-labile enterotoxin.
Lee CH; Masso-Welch P; Hajishengallis G; Connell TD
J Leukoc Biol; 2011 Nov; 90(5):911-21. PubMed ID: 21791597
[TBL] [Abstract][Full Text] [Related]
15. Characterization of antigen-presenting cells induced by intragastric immunization with recombinant chimeric immunogens constructed from Streptococcus mutans AgI/II and type I or type II heat-labile enterotoxins.
Zhao W; Zhao Z; Russell MW
Mol Oral Microbiol; 2011 Jun; 26(3):200-9. PubMed ID: 21545697
[TBL] [Abstract][Full Text] [Related]
16. Dendritic Cell-Mediated Mechanisms Triggered by LT-IIa-B
Lee CH; Hajishengallis G; Connell TD
J Microbiol Biotechnol; 2017 Apr; 27(4):709-717. PubMed ID: 28144014
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb.
Fukuta S; Magnani JL; Twiddy EM; Holmes RK; Ginsburg V
Infect Immun; 1988 Jul; 56(7):1748-53. PubMed ID: 3290106
[TBL] [Abstract][Full Text] [Related]
18. Mucosal immunization of mice using CpG DNA and/or mutants of the heat-labile enterotoxin of Escherichia coli as adjuvants.
McCluskie MJ; Weeratna RD; Clements JD; Davis HL
Vaccine; 2001 Jun; 19(27):3759-68. PubMed ID: 11395211
[TBL] [Abstract][Full Text] [Related]
19. Immunostimulatory activity of LT-IIa, a type II heat-labile enterotoxin of Escherichia coli.
Connell TD; Metzger D; Sfintescu C; Evans RT
Immunol Lett; 1998 Jun; 62(2):117-20. PubMed ID: 9698108
[TBL] [Abstract][Full Text] [Related]
20. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit.
de Haan L; Verweij WR; Feil IK; Holtrop M; Hol WG; Agsteribbe E; Wilschut J
Immunology; 1998 Jul; 94(3):424-30. PubMed ID: 9767427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
